HOME >> BIOLOGY >> NEWS
CSIRO research in greatest biotech show on earth

Australia's national science agency, CSIRO, is mounting a major display of technologies this week at BIO 2004, the world's largest biotechnology conference, being held in San Francisco, USA, from 6-9 June.

CSIRO research being featured includes:

  • Drug Discovery and Development cutting edge structural biology, rational drug design, and protein engineering
  • Therapeutic Delivery better, more efficient ways to speed drugs to their targets
  • Gene Silencing and related techniques powerful new gene technologies to enhance therapies and control plant and animal breeding
  • Diagnostics new approaches to infectious disease identification
  • Biomaterials and Tissue Engineering novel materials for cartilage repair, collagen technologies, biopolymers.
  • Bioprocessing and Functional Foods - production of high value chemicals for the food, pharmaceutical and other industries
  • Bioinformatics sophisticated statistical analysis of complex data sets generated in biotechnology.

"This is the sixth time we have showcased our research at BIO," said Dr Mikael Hirsch, Biotechnology Strategy Coordinator for CSIRO.

"This year we are highlighting our Commercial Opportunities in the Life Sciences," Dr Hirsch added. "It is important that our world class science leads to commercial outcomes for global benefit".

Minister for Industry, Tourism and Resources, The Hon Ian MacFarlane MP, will lead the Australian delegation. The CSIRO delegation of 11 includes senior executives, scientists and business managers.

"The attendance at BIO of a Federal Minister and the Premiers of Victoria, NSW and Queensland underlines the importance Australia places on our international profile in this rapidly moving business and scientific field." said Dr Hirsch.

"We know from previous attendance at this event that Australian Science is a
'"/>

Contact: Geoff Burchfield
Geoff.Burchfield@csiro.au
61-262-766-859
CSIRO Australia
7-Jun-2004


Page: 1 2

Related biology news :

1. CSIRO scientist wins highest global award for fisheries research
2. New drug discovery spin-off from CSIRO
3. Millenium bug found by CSIRO scientists
4. Jurassic Beetle: CSIRO Entomologist Discovers Living Fossil
5. CSIRO Reduces Cellulite In Oranges
6. CSIRO Discovery Fights Cell Ageing
7. Leader in cancer treatment and prevention research honored
8. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
9. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
10. Belgian researchers explore revolutionary approach to angiogenesis
11. Award winning researchers reveal potential new role for Glivec

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: CSIRO research greatest biotech show earth

(Date:5/21/2013)... Using a "patient monitoring" device attached to a whale ... time how fishing lines changed a whale,s diving and ... whales, ability to eat and migrate, depletes their energy ... can result in a slow death. , The scientists ... a Dtag to a two-year-old female North Atlantic right ...
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... available in pharmacies and health stores, phosphatidylserine is ... and soy. Proven to improve cognition and slow ... people experiencing memory impairment. Now a team headed ... of Tel Aviv University,s Department of Human ... supplement improves the functioning of genes involved in ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 During ... is critical to adhere to principles of good ... , Esteemed speaker Dr. Jeremy Lim, Fellow, Clinical ... , ,     Understand the International Conference ... (GCP) and additional regulations for the conduction of ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 Bed ... battle against the pests is still ongoing, a report from ... thousands more for the bed bug treatment. Meanwhile, to be ... an apartment from the costly bed bug exterminator ... 2013, stated that AHA has so far spent ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
Cached News: